Filing detail
8-KCIK 0001003929
UROGEN CORP 8-K
Accession 0001012870-98-001875
Filed Jul 22, 8:00 PM ETSize 606.7 KB
Filed (ET)
Jul 22, 8:00 PM ET
Accepted
—
File size
606.7 KB
SEC accession
0001012870-98-001875
Filing details
- Company
- VIA Pharmaceuticals, Inc.
- CIK
- 0001003929
- Incorporated
- DE
- Entity type
- operating
Related parties
- filerCIK 0001003929
Documents
Attached files
8-K
FORM 8-K
PrimaryOpen file ↗EX-2.1
ASSET PURCHASE AGREEMENT
EX-2.2
AMENDMENT TO ASSET PURCHASE AGREEMENT
EX-2.3
DISTRIBUTION AGREEMENT
EX-2.4
INVESTORS' RIGHTS AGREEMENT
EX-2.5
CREDIT AGREEMENT
EX-2.6
DEVELOPMENTAL COLLABORATION AGREEMENT
EX-2.7
TECHNOLOGY LICENSE AGREEMENT
EX-4.1
CERTIFICATE OF DESIGNATION (SERIES A)
EX-4.2
CERTIFICATE OF DESIGNATION (SERIES B)
EX-4.3
CERTIFICATE OF DESIGNATION (SERIES C)